Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Business Energy and Industrial Strategy
1 Victoria Street
London
SW1H0ET
UK
E-mail: VTFContracts@beis.gov.uk
NUTS: UKI32
Internet address(es)
Main address: https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
General public services
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Advance Purchase Agreement
Reference number: 2611/09/2020
II.1.2) Main CPV code
33651600
II.1.3) Type of contract
Supplies
II.1.4) Short description
Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Contract value is being withheld due to commercial sensitivity (PCR 2015 Reg 50(6)(b) and (c) and FOIA 2000 Section 43). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:
(i) the supplier in its negotiations with other national governments; and
(ii) the contracting authority in negotiations with other vaccine vendors. It may also impact fair competition between vaccine vendors.
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons
Explanation
The award of the contract to Aventis Pharma and GSK is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii).
Furthermore, this Advance Purchase Agreement is the execution of the previous Capacity Reservation Agreement (Please see linked notice)
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2020/S 227-560526
Section V: Award of contract
Contract No: 2611/09/2020
Title: Advance Purchase Agreement
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
20/09/2021
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Aventis Pharma Ltd
Thames Valley Park Drive, Reading
Berkshire
RG6 1PT
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
GlaxoSmithKline Biologicals S.A
Rue de l'Institut 89
Rixensart
B-1330
BE
NUTS: BE
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
Additional information: contract end date is being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)) and commercial sensitivity (Reg 50(6)(b) and (c)). The date is variable based on production and delivery. Given significant challenges to overcome, the end date may set unrealistic expectation for the public/market. Also, given significant competition to bring to the market a successful vaccine, provision of the contract term is valuable information to competitors that may impact negotiations/future competition.
VI.4) Procedures for review
VI.4.1) Review body
Department of Business, Energy and Industrial Strategy
1 Victoria Street, Westminister
London
SW1H 0ET
UK
VI.5) Date of dispatch of this notice
20/10/2021